Novo Boosts Forecast as Wegovy Pill Beats Estimates

Novo Nordisk A/S boosted its forecast for the year, citing sales of its Wegovy weight-loss pill as it continues to fight for a larger share of the obesity market.

By Naomi Kresge · Bloomberg

Novo Nordisk A/S boosted its forecast for the year, citing sales of its Wegovy weight-loss pill as it continues to fight for a larger share of the obesity market.